Search - tctmd.com

Displaying 61 - 80 of 377

Sort: Relevancy | Date

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News ISC 2024

Tirofiban May Cut Early Worsening After Acute Ischemic Stroke

Todd Neale

February 13, 2024

News Conference News ISC 2024

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

Todd Neale

February 09, 2024

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

Todd Neale

February 08, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

News Conference News PCR London Valves 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Presentation TCT 2023

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Presenter: Federico Asch

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Presenter: Marianna Adamo

October 24, 2023

Presentation TCT 2023

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Presenter: JoAnn Lindenfeld

October 24, 2023

Presentation TCT 2023

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Sam Dawkins

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Khung Keong Yeo

October 24, 2023

Presentation TCT 2023

Atrial Secondary MR or TR in HFpEF: How to Treat

Presenter: Sanjiv Shah

October 24, 2023

Advertisement

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Tirofiban May Cut Early Worsening After Acute Ischemic Stroke

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Atrial Secondary MR or TR in HFpEF: How to Treat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content